About us
Who we are?
Our leaders have spent 100+ years working in, and around, a broken health care system. We have become experts at creating work-arounds or temporary fixes on either side of the provider/payer walls.
Deep renal care proficiency, directed by leading nephrologist
AI and machine-learning expertise
Value delivery through identification, prioritization and care management
Why We Exist?
Today’s methods are missing the enormous opportunity in CKD to both lower costs AND improve outcomes.
Yet, we know the answer. We know that early identification is critical. We know that today’s methods don’t identify up to 90% of the population. We know that if you can’t identify the population and prioritize their risk, you will endure clinical & financial risk that is totally unnecessary.
Compass knows that our approach will deliver value by helping you get in front of this avoidable risk.
Our Pledge
We help our partners deliver better care and a better experience to those who find themselves on the wrong end of a kidney-related diagnosis. And we do it without disrupting your internal operations or provider relationships.
Our pledge to you is that we will provide real value should you choose to partner with us. We will stand behind our promises, and we are prepared to put skin in the game to prove it.
meet the team
Patrick lacombe
president & CEO
A nationally recognized leader in risk and cost management of kidney disease, Patrick brings a wealth of experience in managed care and population health, including 10 years developing and leading Optum Health’s Complex Disease Management program, with primary focus on CKD and ESRD. Patrick also held leadership positions at DaVita and Prime Therapeutics. Current board chair of the Twin Cities National Kidney Foundation. Patrick holds a B.S. in Humanities and Russian/East European Studies from the University of Michigan and an MBA from the Wharton School of Management, University of Pennsylvania.
Dr. Alan leichtman
Medical Director
Dr. Leichtman has more than 40 years of experience in internal medicine and nephrology. Current Professor Emeritus, Division of Nephrology, University of Michigan. Former Chief Medical Director of the University of Michigan’s Transplant program. Former Senior Research Scientist at Arbor Research. Dr. Leichtman leads applied analytics, patient identification and risk stratification rules logic, clinical guidance tools and value measurement methodologies. Dr. Leichtman’s research includes the clinical outcomes of kidney and pancreas transplantation, kidney paired donation, and the effects of public policies on solid organ transplantation outcomes.
Melissa lindholm
vP Product management
Melissa brings more than 15 years of healthcare experience focused on complex medical conditions and oncology. At UHG/Optum, she led the growth of the oncology business expanding to new markets and launching new services while at UnitedHealthcare, she led clinical product services supporting the transformation of utilization management. Melissa brings P&L leadership, product development, detailed program execution and management skills including: an understanding of integrated commercial, Medicare and Medicaid programs, provider treatment decision support, network contracting, specialty disease management, clinical operations, marketing, and sales. Melissa holds a B.A. in Economics and Communications from Gustavus Adolphus College and an MBA from the University of Minnesota Carlson School of Management.
tom solberg
VP strategy & Business Development
Tom brings 20 years of marketing, product management and business development experience in complex condition disease management, specialty pharmacy and pharmacy benefit management, along with successful health care consulting experience. Tom led the oncology disease management and networks business at Optum Health, he built and led the Specialty Pharmacy business at Prime Therapeutics, and he led B2C and B2B marketing for UnitedHealthcare. Tom holds a B.S. in Mass Communications/Marketing from St. Cloud State University and a MBA in Marketing from the Carlson School of Management, University of Minnesota.
grant barrick
gTM
A leader in developing and commercializing high-value health care technology, Grant has held numerous executive roles in healthcare technology companies. He has led successful transformations at MinuteClinic/CVS, Wolters Kluwer, ProVation, Sansoro Health, and Ōmcare. He is the Founder & Principal of Barrick Advisory. His work spans leadership roles in Strategy & Innovation, Product Management, Marketing, Sales, and Customer Care. Grant holds a MBA in Strategy & Marketing from Washington University in St. Louis, and a BA in History from Carleton College.
ALBERT CHIEN
LEAD, HEALTH CARE ECONOMICS
With background from Kaiser Permanente, United Healthcare, Blue Shield of California and Optum Health, Albert brings 15 years of experience in health care economics and medical informatics. Albert holds a B.A. in Business Economics and a Master in Economics from Cal State Long Beach, as well as a Master in Public Health and Biostatistics from Loma Linda University.
DR. MARK MATSON
MD, MEDICAL DIRECTOR
Dr. Mark Matson is a former Medical Director and Principal Investigator at Prism Clinical Research, where he became a thought leader in pharmaceuticals and chronic renal disease. He was a co-founder of Iowa’s largest independent multi-specialty practice which grew to more than 50 providers and four dialysis facilities. Dr. Matson is board-certified in nephrology and internal medicine, and has more than 30 years of experience, including 15 years of clinical research. He has led development and implementation of protocols across a broad range of diseases and interventions including the full continuum of CKD. Dr Matson is specifically interested in the development of analytical tools to improve CKD identification and treatment decision support for primary care.